Silymarin and agonistic Fas antibody, CH11, induced A375-S2 cell apoptosis through mitochondrial signal pathway

Chinese Pharmacological Bulletin

Volumn 22, Issue 10, 2006, Pages 1242-1245

  Yang, Xiao Ke ^a   Li, Lin Hao ^a   Zhou, Bei ^a   Wu, Li Jun ^a   Tashiro, Shin Ichi ^b   Onodera, Satoshi ^b   Ikejima, Takashi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

A375 S2 cell; Apoptosis; CH11; Silymarin; Synergism

Indexed keywords

CH11 ANTIBODY; CRYSTAL VIOLET; CYTOCHROME C; FAS ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SILYMARIN;

APOPTOSIS; ARTICLE; CHROMATIN; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; INCUBATION TIME; MITOCHONDRION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 33845513348     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ferenci P, Dragosics B, Ddttrich H, et al, Schneider B. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver[J]. J Hepatol, 1989, 9:105-13.
2. Valenzuela A, Garrido A. Biochemical basis of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin[J]. Biol Res, 1994, 27:105-12.
3. Tyagi A, Agarwal C, Harrison G, et al. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages [J]. Carcinogenesis, 2004, 25 (9):1711-1720.
4. Sharma G, Singh R P, Chan D G, et al. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells [J]. Anticancer Res, 2003, 23 (3B):2649-55.
5. Agarwal C, Singh R P, Dhanalakshmi S, et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells[J]. Oncogene, 2003, 22(51):8271-82.
6. Zi X, Agarwal R. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells ; implications for prostate cancer intervention[J]. Proc Natld Acad Sci USA, 1999, 96(13):7490-5.
7. Li L H, Wu L J, Tashiro Shin-ichi, et al. Preventive effect of silymarin on UV irradiation-induced A375-S2 cell apoptosis [J]. Chin J Pathophysiol, 2005, 21(10):1873-8.
8. Fei X F, Wang B X. Studies on evodiamine induced HeLa cell apoptosis[J]. Acta Pharmaceutica Sinica, 2002, 37(9):673-6.
9. Zhu L J, Chen X Q. The Common Experiment Method of Immunology [M]. Beijing: People's Military Doctor Press, 2000:199-200.
10. Charrier L, Jorry A, Toquet C, et al. Growth phase-dependent expression of ICAD-L/DEF45 modulates the pattern of apoptosis in human colonic cancer cells[J]. Cancer Res, 2002, 62(7):2169-72.
11. Suzuki K, Hino M, Kutsuna H, et al. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1β[J]. J Immunol, 2001, 167(10):5940-7.
12. Lin H Li, Li J W, Bei Z, et al. Silymarin Prevents UV Irradiation-induced S375-S2 Cell Apoptosis[J]. Biol Pharm Bull, 2004, 27 (7):1031-6.
13. Wang C, Wang M W, Tashiro Shin-ichi, et al. Interleukin-1β induces apoptosis in human melanoma A375-S2 cells through caspase pathway[J]. Chin J Pathophysiol, 2004, 20(7):1138-43.
14. Erhardt P, Coopoer G M. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL[J]. J Bio Chem, 1996, 271(30):17601-4.
15. Xia M Y, Wang M W, Tashiro Shin-ichi, et al. Magnolol induces apoptosis via alteration of Bax/Bcl-xL ratio and activation of caspases[J]. Chin Pharmacol Bull, 2005, 21(3):318-22.
16. Zheng X L, Sun H X, Liu X L, et al. Astilbic acid induced COLO 205 cell apoptosis by regulating Bcl-2 and Bax expression and activating caspase-3 [J]. Ada Pharmacologica Sinica, 2004, 25 (8):1090-5.
17. Scorrano L, Oakes S A, Opferman J T, et al. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells[J]. Cancer Res, 2000, 60(16):4386 -90.